ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Banner

Pharmaceutical Sciences

Total Records: 107

Filter Research

Title Research Area Implementing Organisations Funding Organisations Start Year Status
Stereoselective Synthesis of Structurally Diverse Sp3-rich Polycyclic Scaffolds: Generation of High valued New Molecular Entities (NMEs) for GPCR Modulators Pharmaceutical Sciences CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Exploration of Cyclic Diaryliodonium Salts as Biarylating Agents to Generate Medicinally Relevant Biaryl Pharmaceutical Sciences CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Evaluating the transmission powder X-ray diffraction and multivariate data analysis for quantitative phase identification of Active Pharmaceutical Ingredients (APIs) Pharmaceutical Sciences Institute of Chemical Technology Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Substantiation of PI3K/Akt Signaling Pathway in Alzheimer’s disease employing Pharmacological Strategies and their Nano-formulations Pharmaceutical Sciences Chaudhary Bansi Lal University Science and Engineering Research Board (SERB), New Delhi Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Development of in vitro and in vivo drug screening platforms against the chikungunya virus Pharmaceutical Sciences CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh Science and Engineering Research Board (SERB), New Delhi Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Dual-targeted novel combination therapy for triple-negative breast cancer Pharmaceutical Sciences Central University of Punjab Science and Engineering Research Board (SERB), New Delhi Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Pharmacological Intervention using α-Klotho with AT1 Receptor Blocker and Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitor against Diabetic Kidney Disease Pharmaceutical Sciences Birla Institute of Technology and Science Science and Engineering Research Board (SERB), New Delhi Anusandhan National Research Foundation (ANRF) 2024 Ongoing
Novel pharmacological interventions against chronic kidney disease using clinically approved Inodilators, ET-1A antagonists, and Bisphosphonates: drug repurposing approach Pharmaceutical Sciences Birla Institute of Technology and Science Science and Engineering Research Board (SERB), New Delhi Anusandhan National Research Foundation (ANRF) 2024 Ongoing
A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India Pharmaceutical Sciences Lifecare Innovations Private Limited, Gurgaon, Haryana Department of Science and Technology (DST) 2024 Ongoing
In silico discovery and biological evaluation of potential drug molecules to improve the treatment of Bedaquiline and Delamanid resistance in Mycobacterium tuberculosis. Pharmaceutical Sciences University of Hyderabad Department of Science and Technology (DST) 2024 Ongoing
arrowtop